From bench to business: Leading experts delve into the challenges and solutions of translating biomedical research breakthroughs into successful ventures.
Navigating the complex journey to a thriving business venture is no small feat. The path is laden with challenges—from the validation of research findings to the complexities of market dynamics to effective messaging in a noisy, crowded space. Many researchers grapple with the daunting task of translating their ground-breaking studies in drug discovery into tangible, market-ready products.
This endeavour is further intensified by the need to secure funding, manage growth, and position oneself strategically in a competitive landscape.
A recent seminar organised by Co11ab Noveva, Experimental Drug Development Centre (EDDC), and SGInnovate brought together panellists to shed light on how startups can attract investors, other funding avenues and the importance of protecting intellectual property (IP).